Xiaoyan Zhang Dongjiang Sui Dong Wang Lina Zhang Ruiyan Wang
10.3389/fimmu.2021.731774
Front Immunol
2021 Sep 14;12:731774.
bullous pemphigoid glucocorticoid immunotherapy pembrolizumab programmed cell death protein 1
CC BY
https://pubmed.ncbi.nlm.nih.gov/34594337/
Antibodies, Monoclonal, Humanized / adverse effects Drug Eruptions / etiology Immune Checkpoint Inhibitors / adverse effects Pemphigoid, Bullous / chemically induced Skin / drug effects
Antibodies, Monoclonal, Humanized / adverse effects Drug Eruptions / etiology Immune Checkpoint Inhibitors / adverse effects Pemphigoid, Bullous / chemically induced Skin / drug effects Case Reports Aged Drug Eruptions / diagnosis Drug Eruptions / drug therapy Glucocorticoids / therapeutic use Humans Male Methylprednisolone / therapeutic use Pemphigoid, Bullous / diagnosis Pemphigoid, Bullous / drug therapy Skin / pathology Treatment Outcome Antibodies, Monoclonal, Humanized Glucocorticoids Immune Checkpoint Inhibitors pembrolizumab Methylprednisolone
PMC8477373
34594337
Case Report: A Rare Case of Pembrolizumab-Induced Bullous Pemphigoid
2021